Patents by Inventor MICHELLE A. GILL

MICHELLE A. GILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8423945
    Abstract: Techniques, systems, and methods are provided for optimizing pattern density fill patterns for integrated circuits. The method includes adjusting an area of a scribe line and a density of dummy fill shapes in the adjusted scribe line, while maintaining an area of the die, to achieve a pattern density associated with technology ground rules for a particular design of the die.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: April 16, 2013
    Assignee: International Business Machines Corporation
    Inventors: Jeanne P. Bickford, Allan O. Cruz, Michelle Gill, Howard S. Landis, David V. MacDonnell, II, Donald J. Samuels, Roger J. Yerdon
  • Publication number: 20110289470
    Abstract: Techniques, systems, and methods are provided for optimizing pattern density fill patterns for integrated circuits. The method includes adjusting an area of a scribe line and a density of dummy fill shapes in the adjusted scribe line, while maintaining an area of the die, to achieve a pattern density associated with technology ground rules for a particular design of the die.
    Type: Application
    Filed: May 18, 2010
    Publication date: November 24, 2011
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Jeanne P. BICKFORD, Allan O. CRUZ, Michelle GILL, Howard S. LANDIS, David V. MACDONNELL, II, Donald J. SAMUELS, Roger J. YERDON
  • Publication number: 20100061965
    Abstract: The present invention includes compositions, methods and systems for inducing immune tolerance using antigen presenting cells by infecting isolated antigen presenting cells with an effective amount of respiratory syncytial virus (RSV) or portions thereof sufficient to infect the antigen presenting cells and contacting CD4+, CD8+ or both CD4+ T cells and CD8+ T cells with the RSV-infected antigen presenting cells, wherein the CD4+, CD8+ or both CD4 and CD8+ T cells are rendered tolerogenic as measured in vitro by a mixed leukocyte reaction.
    Type: Application
    Filed: June 5, 2009
    Publication date: March 11, 2010
    Applicant: BAYLOR RESEARCH INSTITUTE
    Inventors: JOHN E. CONNOLLY, JACQUES F. BANCHEREAU, MICHELLE A. GILL